--- title: Buy Samsca (Tolvaptan) 15mg 30mg Pills Online description: Samsca (Tolvaptan) is used to treat low sodium levels in the blood associated with heart failure and SIADH. Order from our secure pharmacy. type: product language: en url: https://liabilis.com/order-samsca-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 61.74 price_max: 1008.89 currency: USD offers: - name: 15mg x 10 pills price: 61.74 - name: 15mg x 20 pills price: 121.59 - name: 15mg x 30 pills price: 188.99 - name: 15mg x 60 pills price: 353.39 - name: 15mg x 90 pills price: 521.54 - name: 15mg x 120 pills price: 719.99 - name: 15mg x 180 pills price: 1008.89 - name: 30mg x 10 pills price: 78.84 - name: 30mg x 20 pills price: 164.99 - name: 30mg x 30 pills price: 232.74 - name: 30mg x 60 pills price: 461.69 - name: 30mg x 90 pills price: 680.19 - name: 30mg x 120 pills price: 891.09 --- # Buy Samsca (Tolvaptan) 15mg 30mg Pills Online Samsca, containing Tolvaptan, is a vasopressin receptor antagonist originally developed by Otsuka Pharmaceutical for treating clinically significant hyponatremia (low sodium levels) associated with heart failure, cirrhosis, and syndrome of inappropriate antidiuretic hormone secretion (SIADH). It is designed for adults under medical supervision who need careful fluid and electrolyte management. Our online pharmacy provides access to Samsca in 15mg and 30mg pills. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **15mg** | 10 pills | **$61.74** | $6.17 | In Stock | | **15mg** | 20 pills | **$121.59** | $6.08 | In Stock | | **15mg** | 30 pills | **$188.99** | $6.30 | In Stock | | **15mg** | 60 pills | **$353.39** | $5.89 | In Stock | | **15mg** | 90 pills | **$521.54** | $5.79 | In Stock | | **15mg** | 120 pills | **$719.99** | $6.00 | In Stock | | **15mg** | 180 pills | **$1008.89** | $5.61 | In Stock | | **30mg** | 10 pills | **$78.84** | $7.89 | In Stock | | **30mg** | 20 pills | **$164.99** | $8.25 | In Stock | | **30mg** | 30 pills | **$232.74** | $7.76 | In Stock | | **30mg** | 60 pills | **$461.69** | $7.70 | In Stock | | **30mg** | 90 pills | **$680.19** | $7.56 | In Stock | | **30mg** | 120 pills | **$891.09** | $7.43 | In Stock | [Buy Now](https://liabilis.com/order-samsca-online-en.html) ## Introduction Samsca is a generic oral tablet that contains the active ingredient Tolvaptan. It is a vasopressin V₂-receptor antagonist indicated for the treatment of clinically significant hyponatraemia associated with the syndrome of inappropriate antidiuretic hormone secretion (SIADH), heart failure, or cirrhosis. The medication is supplied as a pill in two strengths - 15 mg and 30 mg - and belongs to the class of aquaretics, agents that promote free water excretion without substantial loss of electrolytes. ## Quick Reference Facts **Active Ingredient** : Tolvaptan **Form** : pill 15 mg | 30 mg **Primary Uses** : - Correction of hyponatraemia due to SIADH, heart failure, or cirrhosis : - Management of autosomal dominant polycystic kidney disease (ADPKD) where approved ## What is Samsca? Samsca is the generic version of medications that contain the selective vasopressin V₂-receptor antagonist Tolvaptan. It is marketed worldwide under brand names such as **Jynarque** (for ADPKD) and **Samsca** (for hyponatraemia). The drug is manufactured by several licensed pharmaceutical companies that meet international quality standards. As a generic product, Samsca delivers the same therapeutic effect as its branded counterparts while offering a lower price point and greater accessibility for patients. ## How Samsca Works Tolvaptan blocks the V₂ receptors located on the basolateral membrane of renal collecting-duct cells. Under normal circumstances, vasopressin (antidiuretic hormone) binds these receptors, activating adenylate cyclase and raising intracellular cyclic AMP. The elevated cAMP promotes insertion of aquaporin-2 water channels into the apical membrane, allowing water reabsorption and concentrating urine. By antagonizing V₂ receptors, Samsca aborts this signalling cascade, resulting in: * **Aquaretic effect** - excretion of free water without accompanying sodium loss, raising serum sodium concentrations. * **Rapid correction of hyponatraemia** - typically within 24 hours, depending on baseline severity and fluid status. * **Reduction of cystic progression in ADPKD** - V₂-receptor blockade lessens cyclic AMP-driven cell proliferation in renal tubular epithelium, slowing cyst growth (observed in clinical trials for the ADPKD indication). The drug is metabolised principally by CYP3A4 in the liver, with a half-life of approximately 12 hours for the 15 mg dose and 15 hours for the 30 mg dose. It is eliminated mainly via biliary excretion; renal clearance is minimal. ## Conditions Treated with Samsca - **Hyponatraemia secondary to SIADH** Excess vasopressin secretion causes water retention and dilutional hyponatraemia. Samsca’s aquaretic action preferentially removes free water, concentrating serum sodium to safe levels. - **Hyponatraemia in heart failure** Congestive heart failure often triggers non-osmotic vasopressin release, worsening fluid overload and low sodium. Blocking V₂ receptors helps correct sodium while reducing volume overload. - **Hyponatraemia in liver cirrhosis** Portal hypertension and ascites stimulate vasopressin release. Samsca improves serum sodium without precipitating hypotension, supporting better encephalopathy management. - **Autosomal dominant polycystic kidney disease (ADPKD)** - where approved In ADPKD, Tolvaptan slows total kidney volume increase and delays the need for dialysis by attenuating cAMP-mediated cyst growth. ## Is Samsca the Right Medication for You? Samsca is appropriate for adult patients who: * Have documented hyponatraemia (serum sodium < 130 mmol/L) caused by SIADH, heart failure, or cirrhosis and require rapid correction. * Possess stable liver function (baseline ALT/AST ≤ 3 × ULN) and no evidence of acute hepatic injury. * Have a urine output capacity that can accommodate the aquaretic effect (≥ 500 mL/day). Clinical scenarios favouring Samsca include: * Persistent hyponatraemia despite fluid restriction. * Need for short-term rapid correction before definitive therapies (e.g., diuretics, transplant evaluation). * Patients with ADPKD who meet eGFR criteria (≥ 30 mL/min/1.73 m²) and can be monitored for liver safety. **Contraindications** include: * Anuria (no urine output) - the drug cannot be eliminated. * Known hypersensitivity to Tolvaptan or any excipients. * Severe hepatic impairment (Child-Pugh C) for the ADPKD indication. * Uncontrolled hypotension or hypovolaemia, as excessive free-water loss may precipitate shock. Patients with moderate liver disease, pregnant or nursing women, and those taking strong CYP3A4 modulators should discuss risks with their clinician before initiating Samsca. ## Buying Samsca from [our online pharmacy](https://liabilis.com/order-samsca-online-en.html) ### Why Choose Our Service? Accessing Samsca can be challenging due to regional formulary restrictions or high out-of-pocket costs. Our platform offers a reliable, cost-effective way to obtain the medication, helping patients maintain continuity of care without financial strain. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. Every batch of Samsca is sourced from manufacturers that adhere to Good Manufacturing Practice (GMP) standards and undergo third-party verification. ### Pricing & Access Because Samsca is a generic formulation, it is priced markedly lower than brand-name equivalents such as Jynarque. Our service provides near-wholesale pricing, making long-term therapy for chronic conditions more affordable. ### Discreet Delivery Orders are packaged in plain, unmarked boxes and shipped via express delivery (typically within 7 days) or standard airmail (approximately 3 weeks). All personal information is protected through encrypted transmission and strict privacy policies. ## Use: Dosing, Missed Dose, Overdose **Standard Dosing** - **Initial therapy for hyponatraemia**: 15 mg orally once daily. Dose may be increased to 30 mg after 24 hours if serum sodium has not risen ≥ 5 mmol/L. - **Maintenance for ADPKD**: Start at 45 mg (split dose) and titrate up to 120 mg daily based on tolerability and liver-function monitoring (per local label). **Missed Dose** - If a dose is missed and it is less than 12 hours until the next scheduled dose, skip the missed tablet and resume the regular schedule. Do not double-dose. **Overdose** - Symptoms may include excessive thirst, polyuria, severe dehydration, and rapid rise in serum sodium. Seek emergency medical care. Treatment focuses on fluid replacement and careful correction of sodium to avoid osmotic demyelination syndrome. **Precautions** - Take with food to minimise gastrointestinal irritation. - Avoid concurrent use of strong CYP3A4 inhibitors (e.g., ketoconazole) unless medically supervised. - Do not operate heavy machinery if experiencing dizziness or visual disturbances. ## Safety Information ### ⚠️ Who Should Not Take Samsca - Patients with anuria or severe renal impairment (eGFR < 15 mL/min/1.73 m²). - Individuals with known hypersensitivity to Tolvaptan or tablet excipients. - Patients with acute or severe hepatic dysfunction (ALT/AST > 3 × ULN). - Pregnant or breastfeeding women - safety not established. ### Common Side Effects - **Thirst** (mild to moderate, occurs in > 30 % of patients). - **Polyuria** (increased urine volume, may lead to nocturia). - **Dry mouth** and mild **headache**. - These effects usually diminish after the first week of therapy. ### Serious Side Effects (Seek Immediate Medical Help) - **Severe liver injury** - manifested by jaundice, right-upper-quadrant pain, or unexplained elevation of liver enzymes. - **Rapid correction of hyponatraemia** - may cause osmotic demyelination syndrome (neurological deficits, seizures). - **Hypotension or dehydration** - marked dizziness, syncope, or electrolyte imbalance. - If any of these occur, discontinue Samsca and contact emergency services. ### Drug & Food Interactions - **CYP3A4 inhibitors** (ketoconazole, itraconazole, clarithromycin) - increase Tolvaptan plasma levels; dose reduction may be required. - **CYP3A4 inducers** (rifampin, carbamazepine, St. John’s wort) - reduce efficacy; avoid or monitor sodium response closely. - **Concomitant NSAIDs** - heighten risk of renal impairment and fluid imbalance. - **Lithium** - enhanced lithium toxicity due to altered renal handling; monitor serum lithium levels. ## Off-Label and Investigational Uses of Samsca - **Hyponatraemia in cancer patients receiving chemotherapy** - small case series suggest benefit when SIADH is chemotherapy-induced, but evidence remains limited. - **Management of ascites in refractory cirrhosis** - off-label use has been explored to reduce water retention, though controlled trials are scarce. - **Adjunct to diuretic therapy in resistant heart failure** - occasional clinical practice incorporates Samsca to augment aquaresis; formal guidelines have not yet endorsed this use. All off-label applications should only be undertaken under direct supervision of a qualified healthcare provider, with careful monitoring for safety. ## Storage & Handling - Store tablets at 20 °C-25 °C (68 °F-77 °F). - Protect from excess heat, moisture, and direct sunlight. - Keep out of reach of children. - Do not use after the printed expiry date; discard unused tablets according to local pharmaceutical waste regulations. ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I travel internationally with Samsca?** Yes, but bring a copy of the prescription and a letter from your clinician describing the medical necessity. Check destination country import rules before departure. - **Will alcohol affect the efficacy of Samsca?** Moderate alcohol intake does not directly interfere with Tolvaptan’s mechanism, but excessive drinking can exacerbate dehydration and increase the risk of hypotension. - **How should I time my dose relative to daily activities?** Taking Samsca in the morning with food helps align the aquaretic effect with daytime fluid intake, reducing nocturnal polyuria. **Product & Formulation Details** - **What do Samsca tablets look like?** The 15 mg tablet is round, white, and debossed “15”. The 30 mg tablet is round, pink, and marked “30”. Tablet appearance may vary slightly between manufacturers. - **Can the tablets be split or crushed?** Tablets are not scored; splitting may result in dose inaccuracy. Crushing is not recommended because it could affect the drug’s release characteristics. **Regulatory & Safety Nuances** - **Will Samsca appear on a standard drug test for athletes?** Tolvaptan is not listed on the World Anti-Doping Agency (WADA) prohibited list, but athletes should disclose any medication use to their governing body. - **Is Samsca safe for elderly patients?** Older adults are more prone to dehydration and hepatic sensitivity. Dose adjustments and close monitoring of serum sodium and liver enzymes are advisable. - **What are the import restrictions for Samsca in the United States?** The FDA permits personal import of prescription medicines for personal use under certain conditions, provided the medication is not for a controlled substance and the importing individual possesses a valid prescription. **Scientific & Clinical Curiosity** - **What major trial established Tolvaptan’s benefit in ADPKD?** The TEMPO 3:4 trial demonstrated a statistically significant reduction in total kidney volume growth and slower decline in eGFR over three years compared with placebo. - **How does Tolvaptan differ from traditional diuretics?** Unlike loop or thiazide diuretics, Tolvaptan promotes excretion of free water without substantial loss of sodium or potassium, thereby correcting hyponatraemia rather than causing natriuresis. ## Glossary **V₂-receptor antagonist** : A drug that blocks vasopressin-type-2 receptors in the kidney, preventing water reabsorption and promoting free-water excretion. **Osmotic demyelination syndrome** : A severe neurologic condition caused by overly rapid correction of low serum sodium, leading to damage of the myelin sheath in the brainstem. **Bioequivalence** : Demonstration that a generic product delivers the same amount of active ingredient into the bloodstream as the reference branded drug, within an accepted range of variability. **eGFR** : Estimated glomerular filtration rate, a calculation used to assess kidney function based on serum creatinine, age, sex, and body size. ## Disclaimer The information presented about **Samsca** is intended for general educational purposes and does not replace personalized medical advice. Treatment decisions-including any off-label applications-should be made under the direct supervision of a qualified healthcare professional. Readers are presumed to be responsible adults capable of evaluating health information critically. [our online pharmacy](https://liabilis.com/order-samsca-online-en.html) provides access to **Samsca** for individuals who may encounter limited availability through conventional channels or who seek more affordable generic alternatives. Always consult your physician before initiating, modifying, or discontinuing any medication.